Reference
- Bernstein R. M., Myers A., Symons C. Clinical and pharmacodynamic aspects of slow release and conventional propranolol in hypertension. Br. J. Clin. Pract. 1982; 20: 55–58, Suppl.1. Bernstein R. M., Myers A., Symons C. Clinical and pharmacodynamic aspects of slow release and conventional propranolol in hypertension. Br. J. Clin. Pract. 1982; 20: 55–58, Suppl.
- Beta-Blocker Heart Attack Trial Research Group A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. J.A.M.A. 1982; 247: 1707–17142. Beta-Blocker Heart Attack Trial Research Group A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. J.A.M.A. 1982; 247: 1707–1714
- Di Salle E., Baker K. M., Bareggi S. R., Watkins W. D., Chidsey C. A., Frigerio A., Marselli P. L. A sensitive gas chromatographic method for the determination of propranolol in human plasma. J. Chromatogr. 1973; 84: 3473. Di Salle E., Baker K. M., Bareggi S. R., Watkins W. D., Chidsey C. A., Frigerio A., Marselli P. L. A sensitive gas chromatographic method for the determination of propranolol in human plasma. J. Chromatogr. 1973; 84: 347
- Fearon R. E. Propranolol in the prevention of ventricular fibrillation due to experimental coronary artery occlusion. Am. J. Cardiol. 1967; 20: 222–2284. Fearon R. E. Propranolol in the prevention of ventricular fibrillation due to experimental coronary artery occlusion. Am. J. Cardiol. 1967; 20: 222–228
- Harris A. Long term treatment of paroxysmal cardiac arrhythmias with propranolol. Am. J. Cardiol. 1966; 18: 431–4365. Harris A. Long term treatment of paroxysmal cardiac arrhythmias with propranolol. Am. J. Cardiol. 1966; 18: 431–436
- Lidell C., Rehnqvist N., Sjogren A., Yli-Uotila R. J., Ronnevik P. K. Comparative efficacy of oral sotalol and procainamide in patients with chronic ventricular arrhythmias: a multicentre study. Am. Heart J. 1985; 109: 970–9756. Lidell C., Rehnqvist N., Sjogren A., Yli-Uotila R. J., Ronnevik P. K. Comparative efficacy of oral sotalol and procainamide in patients with chronic ventricular arrhythmias: a multicentre study. Am. Heart J. 1985; 109: 970–975
- Menken U., Wiegand V., Bucher B., Meesmann W. Prophylaxis of ventricular fibrillation after acute experimental coronary occlusion by chronic beta-adrenoceptor blockade with atenolol. Cardiovasc. Res. 1979; 13: 588–5947. Menken U., Wiegand V., Bucher B., Meesmann W. Prophylaxis of ventricular fibrillation after acute experimental coronary occlusion by chronic beta-adrenoceptor blockade with atenolol. Cardiovasc. Res. 1979; 13: 588–594
- Nixon J. V., Pennington W., Ritter W., Shapiro W. Efficacy of propranolol in the control of exercise-induced or augmented ventricular ectopic activity. Circulatio. 1978; 57: 115–1228. Nixon J. V., Pennington W., Ritter W., Shapiro W. Efficacy of propranolol in the control of exercise-induced or augmented ventricular ectopic activity. Circulatio. 1978; 57: 115–122
- Parkin D. M., Henney C. R., Quirk J., Crooks J. Deviation from prescribed drug treatment after discharge from hospital. Br. Med. J. 1976; 2: 686–6889. Parkin D. M., Henney C. R., Quirk J., Crooks J. Deviation from prescribed drug treatment after discharge from hospital. Br. Med. J. 1976; 2: 686–688
- Sandler G., Pistevos A. C. Use of oxprenolol in cardiac arrhythmias associated with acute myocardial ischaemia. Br. Med. J. 1971; 1: 254–25710. Sandler G., Pistevos A. C. Use of oxprenolol in cardiac arrhythmias associated with acute myocardial ischaemia. Br. Med. J. 1971; 1: 254–257
- Shand D. G. Pharmacokinetic properties of the beta-adrenergic receptor blocking drugs. Drug. 1974; 7: 39–4711. Shand D. G. Pharmacokinetic properties of the beta-adrenergic receptor blocking drugs. Drug. 1974; 7: 39–47
- Singh B. N., Jewitt D. E. Beta-adrenergic receptor blocking drugs in cardiac arrhythmias. Drug. 1974; 7: 426–46112. Singh B. N., Jewitt D. E. Beta-adrenergic receptor blocking drugs in cardiac arrhythmias. Drug. 1974; 7: 426–461